Everspan organizes published research for informational purposes only. This is not medical advice. Consult a healthcare provider before starting any intervention.
Trending
Back to Atlas
T2· OptimizationB+· GoodDeviceOther
Metabolic Health

Continuous Glucose Monitoring

Real-time glucose tracking device that provides continuous blood sugar insights for metabolic optimization.

Human Trials

87

12,400 participants

Risk Level

Low Risk

Monthly Cost

$70$350 /month

Varies by brand, subscription model, and insurance coverage

Quick Facts

Category
Device
Research Field
Other
Evidence Grade
B+ – Good
Risk Level
Low
Monthly Cost
$70 – $350
Human Trials
87
Where to Source·Prescription required – consult your healthcare provider

Research Velocity

+24%
245 publications in the last 12 months · steady increase in publications

Mechanism of Action

Uses a small subcutaneous sensor to measure glucose levels in interstitial fluid every 1-15 minutes. The sensor transmits data wirelessly to a receiver or smartphone app, providing real-time glucose trends and alerts. This continuous monitoring allows users to observe how diet, exercise, stress, and sleep affect their glucose patterns.

Overview

Continuous Glucose Monitoring (CGM) devices have emerged from diabetes management tools to become popular metabolic optimization instruments for health-conscious individuals. Research indicates that CGM provides valuable insights into how various lifestyle factors affect glucose patterns, even in non-diabetic populations. Studies suggest that real-time glucose data can help users identify foods that cause significant glucose spikes, optimize meal timing, and understand the metabolic impact of exercise, stress, and sleep patterns.

The technology works by inserting a thin sensor filament under the skin, typically on the arm or abdomen, which measures glucose in interstitial fluid. Modern CGMs can transmit data continuously to smartphones, providing trends, alerts, and historical data analysis. Research shows that individuals using CGM often develop better awareness of their metabolic responses and may make more informed dietary and lifestyle choices. Studies indicate that even people with normal glucose tolerance can experience significant variability in their glucose responses to identical meals, making personalized monitoring potentially valuable for metabolic optimization.

While originally designed for diabetes management, growing research suggests CGM may benefit athletes seeking performance optimization, individuals interested in metabolic health, and those exploring personalized nutrition approaches. However, experts emphasize that glucose is just one biomarker among many, and CGM data should be interpreted within the broader context of overall health and wellness goals rather than as a standalone health metric.

Known Interactions

  • Acetaminophen can interfere with glucose oxidase-based sensors, causing falsely elevated readings
  • Sensor accuracy may be reduced during rapid glucose changes or in dehydrated states
  • Adhesive reactions possible in individuals with sensitive skin
  • Some sensors require calibration with fingerstick blood glucose measurements

Legal Status by Country

📍

Your country (United States)

FDA-approved devices available over-the-counter

OTC
✈️

Available without prescription in:

Australia, Canada, Germany, United Kingdom, United States

Australia
OTC
Canada
OTC
Germany
OTC
United Kingdom
OTC
📍United States
OTC
✈️Brazil
Rx Required
China
Rx Required
✈️Colombia
Rx Required
✈️India
Rx Required
✈️Israel
Rx Required
Japan
Rx Required
✈️Mexico
Rx Required
Netherlands
Rx Required
✈️Panama
Rx Required
Russia
Rx Required
✈️South Korea
Rx Required
Switzerland
Rx Required
✈️Thailand
Rx Required
✈️Turkey
Rx Required
✈️UAE
Rx Required

📍 = your selected country · ✈️ = medical tourism destination · Always verify current local regulations before travel.

Key Research

Last verified: 2026-03-16